Cellulitis Treatment Market Projected to Garner Significant Revenues by 2026

Cellulitis is one of the common skin infections caused by bacteria; mostly streptococcus sp. and staphylococcus sp. According to a study published by the AMA Journal of Ethics, cellulitis is defined as an acute inflammatory disorder which takes place in dermis and subcutaneous layer of the tissue. It can occur in any part of the body; however, lower legs and surrounding areas of wrist and fingers (face and neck in children) are mostly infected by streptococcus sp. and staphylococcus sp. Common symptoms of cellulitis include swelling, skin redness, fever, red spots, and skin dimpling.

Cellulitis can begin with any break of the skin, for example, minor scratch or insect bites which permits bacteria to enter the deeper layers of the skin. Health care practitioners indicate that cellulitis is high among healthy adults. It mostly occurs in children and adults who have weakened immune system.

Proper usage of antibacterial drugs are adequate to treat cellulitis. The global Cellulitis Treatment Market is primarily driven by increase in cases of cellulitis across the world, rise in diagnosis & treatment rate of cellulitis, and improving health care infrastructure. However, stringent regulatory guidelines and less public awareness are projected to hamper the growth of the global cellulitis treatment market during the forecast period. Ongoing clinical trials on antibacterial drugs, increase in R&D investment by major players, and mergers & acquisitions among the key players are anticipated to propel the global market from 2018 to 2026.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58959

In terms of drug class, the global cellulitis treatment market can be segmented into glycopeptide, fluoroquinolone, dehydropeptidase inhibitors, macrolide, cephalosporin, and others. Based on route of administration, the global market can be classified into enteral, parenteral, and others. In terms of drug type, the global cellulitis treatment market can be bifurcated into branded and generic. Based on distribution channel, the global market can be categorized into hospital pharmacies, retail pharmacies & drug stores, and others.

Key companies in the global cellulitis treatment market are Sun Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd, Novartis AG, Shionogi & Co., Ltd., and Pfizer, among others.

Be the first to comment

Leave a Reply

Your email address will not be published.


*